Hamilton Lane (NASDAQ:HLNE) Price Target Lowered to $167.00 at Keefe, Bruyette & Woods

Hamilton Lane (NASDAQ:HLNE) had its price target reduced by stock analysts at Keefe, Bruyette & Woods from $215.00 to $167.00 in a note issued to investors on Friday,Benzinga reports. The firm currently has a “market perform” rating on the stock. Keefe, Bruyette & Woods’ price target suggests a potential upside of 10.30% from the company’s current price.

A number of other analysts have also commented on HLNE. Wells Fargo & Company lifted their price target on Hamilton Lane from $189.00 to $194.00 and gave the stock an “equal weight” rating in a report on Thursday, December 12th. Morgan Stanley lifted their target price on Hamilton Lane from $182.00 to $190.00 and gave the stock an “equal weight” rating in a research note on Monday, November 11th. The Goldman Sachs Group raised their price objective on shares of Hamilton Lane from $139.00 to $147.00 and gave the stock a “neutral” rating in a report on Thursday, October 3rd. JPMorgan Chase & Co. increased their price target on shares of Hamilton Lane from $134.00 to $175.00 and gave the stock a “neutral” rating in a report on Thursday, November 7th. Finally, UBS Group upped their price objective on shares of Hamilton Lane from $150.00 to $185.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 22nd. Seven research analysts have rated the stock with a hold rating, According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $176.33.

Hamilton Lane Stock Performance

Shares of HLNE stock opened at $151.40 on Friday. The company has a quick ratio of 3.37, a current ratio of 3.37 and a debt-to-equity ratio of 0.24. Hamilton Lane has a 52 week low of $103.42 and a 52 week high of $203.72. The firm has a 50 day moving average of $183.43 and a 200-day moving average of $156.09. The company has a market cap of $8.39 billion, a price-to-earnings ratio of 32.84 and a beta of 1.19.

Hamilton Lane (NASDAQ:HLNE) last announced its earnings results on Wednesday, November 6th. The company reported $1.07 EPS for the quarter, beating the consensus estimate of $1.06 by $0.01. Hamilton Lane had a net margin of 28.03% and a return on equity of 35.59%. The company had revenue of $150.00 million during the quarter, compared to the consensus estimate of $151.55 million. During the same quarter in the prior year, the company posted $0.89 earnings per share. The firm’s revenue for the quarter was up 18.2% on a year-over-year basis. On average, equities analysts forecast that Hamilton Lane will post 4.87 earnings per share for the current year.

Institutional Trading of Hamilton Lane

Institutional investors have recently made changes to their positions in the stock. Fifth Third Bancorp lifted its stake in shares of Hamilton Lane by 106.5% during the 2nd quarter. Fifth Third Bancorp now owns 694 shares of the company’s stock valued at $86,000 after buying an additional 358 shares in the last quarter. EFG Asset Management North America Corp. lifted its holdings in shares of Hamilton Lane by 0.5% in the second quarter. EFG Asset Management North America Corp. now owns 17,185 shares of the company’s stock worth $2,125,000 after buying an additional 81 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of Hamilton Lane by 6.3% during the second quarter. Bank of New York Mellon Corp now owns 239,623 shares of the company’s stock worth $29,613,000 after acquiring an additional 14,214 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Hamilton Lane by 3.0% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 8,340 shares of the company’s stock valued at $1,031,000 after acquiring an additional 242 shares in the last quarter. Finally, F M Investments LLC bought a new stake in Hamilton Lane in the 2nd quarter valued at $413,000. Hedge funds and other institutional investors own 97.40% of the company’s stock.

About Hamilton Lane

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.